Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nexus Medical Labs is a CLIA and CAP-accredited diagnostic laboratory specializing in scalable molecular and clinical testing solutions. Originating from the Harvard University COVID lab’s efforts during the pandemic, it leverages advanced automation—including the RHINOstic™ swab system—to deliver rapid turnaround times and high-volume processing. The company provides comprehensive panels for STIs and infectious diseases with customizable options. In May 2022 it received FDA Emergency Use Authorization for its SARS-CoV‑2 test using automated nasal swabs. No published clinical trial results as would be typical of therapeutics companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nexus Medical Labs.